The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma.
Lin ZZ, Hsu HC, Hsu CH, Yeh PY, Huang CY, Huang YF, Chen TJ, Kuo SH, Hsu C, Hu FC, Jeng YM, Chung Y, Cheng AL.
Lin ZZ, et al. Among authors: hsu c, hsu hc, hsu ch.
J Hepatol. 2009 Mar;50(3):518-27. doi: 10.1016/j.jhep.2008.10.022. Epub 2008 Dec 25.
J Hepatol. 2009.
PMID: 19155085